Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia.

Current treatment options in oncology - 21 Apr 2020

Reville Patrick K, Kadia Tapan

Abstract excerpt

OPINION STATEMENT: There is increasing awareness that AML is a widely heterogeneous disease, not only based on clinical characteristics and demographics of the patients we treat but also based on the genomics of the disease. Wider accessibility to next-generation DNA sequencing in AML has identified recurrent genetic abnormalities that drive disease biology, define overall prognosis, and predict for response to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Clinical Decision-Making
Share to Disease Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Susceptibility

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Precision Medicine

Source

Identifiers

PMID: 32318829
DOI: 10.1007/s11864-020-0710-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia.PMID 32318829Read ↗

An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.Semantic proximity Read ↗

A precision medicine classification for treatment of acute myeloid leukemia in older patients.Semantic proximity Read ↗

The Evolving AML Genomic Landscape: Therapeutic Implications.Semantic proximity Read ↗

Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial.Semantic proximity Read ↗

A precision medicine approach to management of acute myeloid leukemia in older adults.Semantic proximity Read ↗

New drugs for acute myeloid leukemia inspired by genomics and when to use themSemantic proximity Read ↗

Acute myeloid leukemia: 2014 update on risk-stratification and management.Semantic proximity Read ↗

Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia.Semantic proximity Read ↗

Putting the I in AML: Artificial Intelligence and Machine Learning in Acute Myeloid LeukemiaSemantic proximity Read ↗

Individualizing kinase-targeted cancer therapy: the paradigm of chronic myeloid leukemia.Semantic proximity Read ↗

Integrative analysis of drug response and clinical outcome in acute myeloid leukemiaSemantic proximity Read ↗

Combining clinical and molecular data for personalized treatment in acute myeloid leukemia: A machine learning approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.